GT Biopharma, Inc.
USD0.46
+0.02 (+4.55%)
CEO
Michael Martin Breen
IPO Date
2018-03-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.44
Prev. Close
$0.44
Day Low
$0.43
Day High
$0.46
52W Low
$0.26
52W High
$3.73
Market Cap
$0.00B
Volume
0.27M
| 100,000 |
| $1.33 |
| 8 Sept 2025 | URBAN ALAN LOUIS | Chief Financial Officer | A-Award | Acquired | 50,000 | $1.33 |
| 8 Sept 2025 | CASAMENTO CHARLES J | director | A-Award | Acquired | 62,500 | $1.33 |
| 8 Sept 2025 | Kramer Hilary | director | A-Award | Acquired | 31,250 | $1.33 |
| 30 Jul 2025 | Mun-Gavin David C. | director: | Disposed | 0 | $0.00 |
| 3 Jun 2025 | Kramer Hilary | director: | Disposed | 0 | $0.00 |
| 29 May 2025 | Ritter Andrew J | director: | Disposed | 0 | $0.00 |
| 21 Oct 2024 | URBAN ALAN LOUIS | Chief Financial Officer | A-Award | Acquired | 23,335 | $2.11 |
| 13 Jun 2024 | URBAN ALAN LOUIS | officer | Disposed | 0 | $0.00 |